Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PU-H71 |
| Trade Name | |
| Synonyms | NSC 750424|PUH71|PU H71 |
| Drug Descriptions |
PU-H71 selectively inhibits Heat shock protein 90 (Hsp90), resulting in increased proteosomal degradation of oncogenic client proteins and potentially leading to decreased tumor growth (PMID: 28808818, PMID: 32156599). |
| DrugClasses | HSP90 Inhibitor 35 |
| CAS Registry Number | 873436-91-0 |
| NCIT ID | C101227 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Buparlisib + PU-H71 | Buparlisib PU-H71 | 0 | 0 |
| Dactolisib + PU-H71 | Dactolisib PU-H71 | 0 | 0 |
| Nab-paclitaxel + PU-H71 | Nab-paclitaxel PU-H71 | 0 | 1 |
| PU-H71 | PU-H71 | 0 | 3 |
| PU-H71 + Ruxolitinib | PU-H71 Ruxolitinib | 0 | 1 |